Four-day infusion of fluorouracil plus vinorelbine as salvage treatment of heavily pretreated metastatic breast cancer

Breast Cancer Research and Treatment

Volumn 61, Issue 3, 2000, Pages 241-247

  Zambelli, A ^a   Robustelli della Cuna, F S ^a   Ponchio, L ^a   Ucci, G ^a   Da Prada, G A ^a   Robustelli della Cuna, G ^a  

^a IRCCS   (Italy)

Author keywords

Advanced breast cancer; Continuous infusion chemotherapy

Indexed keywords

ALLOPURINOL; ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; LIDOCAINE; MITOXANTRONE; NAVELBINE; NYSTATIN; PACLITAXEL; TETRACAINE;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RISK; CARDIOTOXICITY; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; FEBRILE NEUTROPENIA; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; METASTASIS; MUCOSA INFLAMMATION; PATIENT ATTITUDE; PHLEBITIS; PRIORITY JOURNAL; SALVAGE THERAPY; STOMATITIS; SURVIVAL TIME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; MIDDLE AGED; PATIENT SELECTION; PROSPECTIVE STUDIES; SALVAGE THERAPY; TREATMENT OUTCOME; VINBLASTINE;

EID: 0033861342     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006462023110     Document Type: Article

References (25)

1. Primary chemotherapy in operable breast cancer
2. Current and future trends in the multidisciplinary approach of high-risk breast cancer: The experience of the Milan Cancer Institute
3. Improved disease-free and overall survival from the addition of sequential paclitaxel, but not from the escalation of doxorubicin dose level in the adjuvant chemotherapy of patients with node positive primary breast cancer
4. High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose therapy for high-risk primary breast cancer
5. Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: Five year results
6. High-dose chemotherapy with hematopoletic rescue as primary treatment for metastatic breast cancer: A randomized clinical trial
7. Paclitaxel (Taxol) Investigators' Workshop
8. The impact of docetaxel (Taxotere) on current treatment
9. The current status of vinorelbine (Navelbine) in breast cancer
10. Vinorelbine (Navelbine) as salvage treatment of advanced breast cancer
11. 5-fluorouracil by protracted intravenous infusion: A review of recent clinical studies
12. Infusional 5-fluorouracil in breast cancer
13. Assessment of response to therapy in advanced breast cancer
14. Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide cardioangiography
15. Reporting results of cancer treatment
16. Nonparametric estimation for incomplete observation
17. Asymptotically efficient rank invariant test procedures
18. Collection of circulating progenitor cells after epirubicin, paclitaxel and filgrastim in patients with metastatic breast cancer
19. Treatment of breast cancer
20. Paclitaxel (Taxol)
21. Doxorubicin-induced cardiomiopathy
22. Salvage chemotherapy of breast cancer
23. Efficacy and tolerance of vinorelbine and fluorouracil combination as first-line chemotherapy of advanced breast cancer: Results of a phase II study using a sequential group method
24. A US multi-center phase II study of iv Navelbine (NVB) and 5 fluorouracil (5FU) as first line treatment of patients with advanced breast cancer (ABC)
25. Five-day infusion fluorouracil plus vinorelbine iv in metastatic pretreated breast cancer